Relmada Therapeutics, Inc. (RLMD)

4.37 -0.46 (-9.52%) USD  |  NASDAQ  |  Jan 02, 16:00
4.37 0.00 (0.00%) Pre-Market: 08:35
More

Relmada Therapeutics EPS Diluted (TTM): -1.797 for Sept. 30, 2025

EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Amicus Therapeutics, Inc. -0.0446
Invivyd, Inc. -0.4735
Arcellx, Inc. -3.918
Puma Biotechnology, Inc. 0.7407
NovaBay Pharmaceuticals, Inc. 0.5953